News
What’s happening in NF1 research today
NTAP Announces Request for Proposals to Develop Patient Reported Outcome Measures
Baltimore, MD (March 15, 2013) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced a request for proposals (RFP) for the development of Patient Reported Outcome (PRO) measures that can be used to support clinical development of […]
Read MoreNTAP Announces Biomarker Development Idea Challenge
Baltimore, MD (January 15, 2013) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced the launch of an idea challenge for the development of biomarkers for neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (pNF). Individuals with pNF can […]
Read MoreNTAP Announces Request for Proposals to Develop Cell Culture Models of Plexiform Neurofibromas
[vc_row][vc_column][vc_column_text margin_bottom=”10″]Baltimore, MD (October 1, 2012) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced a request for proposals (RFP) for the development of novel cell culture models for neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (pNF). Cell […]
Read MoreNTAP hosts 2012 Plexiform Neurofibroma Research Summit
[vc_row][vc_column][vc_column_text margin_bottom=”10″]Baltimore, MD (September 22, 2012) Neurofibromatosis Therapeutic Acceleration Program (NTAP) held its inaugural Plexiform Neurofibroma Scientific Summit on September 20-22, 2012. Held at Nemacolin Woodlands Resort, the summit focused on defining existing resources and […]
Read MoreNTAP announces launch of operations
[vc_row][vc_column][vc_column_text margin_bottom=”10″]Baltimore, MD (June 8, 2012) Today, the Neurofibromatosis Therapeutic Acceleration Program (NTAP) announced the launch of its operations, dedicated to improving treatment options for individuals with plexiform neurofibromas (pNFs). NTAP is a non-profit organization […]
Read More